Federal Regulations

After Congress passes a law, federal agencies write the detailed rules that make it real. Each rulemaking project gets a — and while a rule is proposed, anyone can comment on it.

12,572

rulemaking dockets

4,612

open for public comment

You can weigh in on these right now

Showing 30 of 12,572 dockets

Nonrulemaking

EPA

Open for Comments

EPA-HQ-OECA-2011-0824

EPA Seeks Comment on Forms for Pesticide and Device-Producing Facilities

15 docs6 comments

Comments due Sep 29, 2026

Nonrulemaking

FDA

Open for Comments

FDA-2025-P-7321

Requests that the FDA Open a Docket, Hold a Part 15 Public Hearing Regarding the Off-Label Use of Estrogen in Natal Males for Gender Affirmation, and Consider Regulatory Action Including a Boxed Warning Under 21 C.F.R. § 201.80(e)

3 docs10K comments

Nonrulemaking

FDA

Open for Comments

FDA-2026-P-8331

Request that the FDA grant public disclosure of the clinical pharmacology / bioavailability data supporting the approval of Tylenol with Naproxen (acetaminophen 325 mg / naproxen sodium 110 mg fixed-dose combination tablets), approved July 24, 2026, Kenvue Brands LLC

2 docsNo comments

Nonrulemaking

CNCS

Open for Comments

CNCS-2026-0133

AmeriCorps Seeks Approval to Renew VISTA Application and Reporting Forms — Public Comments Open

7 docs1 comment

Comments due Sep 1, 2026

Nonrulemaking

FDA

Open for Comments

FDA-2015-D-4750

Implementation of the “Deemed to be a License” Provision of the Biologics Price Competition and Innovation Act of 2009

14 docs5.3K comments

Comments due Feb 12, 2019

Nonrulemaking

FDA

FDA-2026-H-6502

DAB Civil Money Penalty; Gnan & Anant Inc. d/b/a Quinebaug Smoke Shop; CLOSED 07/30/2026

1 docNo comments

Nonrulemaking

FDA

FDA-2026-H-7098

DAB Civil Money Penalty; KLP Holdings LLC d/b/a 21 Plaza Wine & Liquors; CLOSED 07/30/2026

1 docNo comments

Nonrulemaking

HUD

Open for Comments

HUD-2026-0958

HUD sets 2.337% national inflation adjustment for 2026 housing voucher renewal funding

1 doc14 comments

Comments due Aug 6, 2026

Nonrulemaking

DOS

Open for Comments

DOS-2026-0694

State Department Seeks Public Comment on Medical Exam Form for Visa and Immigration Applications

8 docs18 comments

Comments due Aug 11, 2026

Nonrulemaking

FDA

Open for Comments

FDA-2011-N-0656

FDA Seeks Stakeholders for Meetings on Reauthorizing Animal Drug User Fee Law

29 docs1.4K comments

Comments due Dec 2, 2027

Nonrulemaking

FDA

Open for Comments

FDA-2025-P-1981

Requests that the FDA initiate rulemaking to switch ivermectin oral tablet products from prescription-only status to full over-the-counter status.

3 docs1.4K comments

Nonrulemaking

FDA

FDA-2026-H-8195

DAB Civil Money Penalty: 7 Blessings LLC d/b/a 7 Blessings Smoke Shop

1 docNo comments

Nonrulemaking

EPA

EPA-HQ-OPPT-2023-0105

Regulation of Persistent, Bioaccumulative, and Toxic Chemicals under TSCA Section 6(h); Renewal Collection and Request for Comment

5 docsNo comments

Nonrulemaking

FDA

Open for Comments

FDA-2026-D-2839

FDA Seeks Comment on Streamlined Safety Studies for Cancer biologics to Reduce Animal Use

2 docs43 comments

Comments due Aug 1, 2026

Nonrulemaking

FDA

FDA-2026-H-4360

DAB Civil Money Penalty; Tkban, Inc. d/b/a Food Mart / Chevron; CLOSED 07/30/2026

1 docNo comments

Nonrulemaking

FAA

Open for Comments

FAA-2026-7729

Farm Flight Aerial Ag Inc. - Exemption/Rulemaking

3 docsNo comments

Nonrulemaking

FDA

FDA-2026-H-8194

DAB Civil Money Penalty; Leyla Mustafa d/b/a La Central

1 docNo comments

Rulemaking

EPA

Open for Comments

EPA-R09-OAR-2025-0166

EPA proposes removing emergency defense clauses from four California air district permits

9 docsNo comments

Comments due Sep 1, 2026

Nonrulemaking

FDA

FDA-2026-E-8234

Patent Term Extension Application for ProVee® System for BPH, Patent No. 10,881,539

2 docsNo comments

Nonrulemaking

FDA

FDA-2026-E-8233

Patent Term Extension Application for ProVee® System for BPH, Patent No. 10,682,245

2 docsNo comments

Nonrulemaking

FDA

FDA-2026-E-8232

Patent Term Extension Application for LIFYORLI® (relacorilant), Patent No. 11,576,907

2 docsNo comments

Nonrulemaking

FDA

FDA-2026-E-8230

Patent Term Extension Application for LIFYORLI® (relacorilant), Patent No. 10,456,392

2 docsNo comments

Nonrulemaking

FDA

FDA-2026-E-8229

Patent Term Extension Application for LIFYORLI® (relacorilant), Patent No. 9,273,047

2 docsNo comments

Nonrulemaking

FDA

FDA-2026-E-8228

Patent Term Extension Application for LIFYORLI® (relacorilant), Patent No. 8,859,774

2 docsNo comments

Nonrulemaking

FDA

FDA-2026-E-8227

Patent Term Extension Application for ICOTYDE® (icotrokinra), Patent No. 12,552,836

2 docsNo comments

Nonrulemaking

USBC

Open for Comments

USBC-2026-0133

OMB Seeks Public Comment on Proposed 2027 Updates to Industry Classification System

1 doc50 comments

Comments due Aug 13, 2026

Nonrulemaking

FAA

Open for Comments

FAA-2026-9109

Tidewater Ag & Construction Equipment, LLC - Exemption/Rulemaking

1 docNo comments

Nonrulemaking

FDA

FDA-2026-E-8226

Patent Term Extension Application for AWIQLI® (insulin icodec-abae), Patent No. 9,045,560

2 docsNo comments

Nonrulemaking

FDA

FDA-2026-E-8225

Patent Term Extension Application for AVLAYAH® (tividenofusp alfa-eknm), Patent No. 10,870,837

2 docsNo comments

Nonrulemaking

FAA

Open for Comments

FAA-2026-7690

Agdrone Authority LLC - Exemption/Rulemaking

3 docsNo comments